Last reviewed · How we verify
NCT04120740
Validation of Two Acitivity Monitors in Three Inpatient Populations.
trial in Hip Fractures in 36 participants. Completed in 18 November 2019.
18 November 2019
Quick facts
| Lead sponsor | Mette Merete Pedersen |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 36 |
| Start date | 10 October 2019 |
| Primary completion | 18 November 2019 |
| Estimated completion | 18 November 2019 |
| Sites | 1 location across Denmark |
Conditions studied
- Hip Fractures — all drugs for Hip Fractures →
- Abdominal Surgery — all drugs for Abdominal Surgery →
- Medical Patients — all drugs for Medical Patients →
Sponsor
Mette Merete Pedersen
Who can join
18 and older, any sex, with Hip Fractures or Abdominal Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the validity of Sens Motion and ActivPAL acitivity monitors. Thirthy-six patients from three different patient populations will be included: 12 acute high-risk abdominal surgery patients (+18 years), 12 hip fracture patients (+65) and 12 older medical patients (+65). Each patient will be asked to wear two sets of activity monitors while performing a predefined researcher-supervised protocol consisting of a range of positions and activities including lying down, sitting, standing and walking. Observations measured by time in each position will be used as a golden standard for physical activity and thus compared with the data produced by the acitivity monitors.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Validation of Two Activity Monitors in Slow and Fast Walking Hospitalized Patients.
Pedersen BS, Kristensen MT, Josefsen CO, Lykkegaard KL, et al · · 2022 · cited 32× · PMID 35615755 · DOI 10.1155/2022/9230081
Verify or expand the search:
- PubMed search for NCT04120740
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Fractures
Currently open trials in the same condition.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
- NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
- NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
- NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04120740 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mette Merete Pedersen
- Last refreshed: 21 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04120740.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing